Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
N.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.11 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.11 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.11 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.11 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.435ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.435ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.435ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.435NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.445ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.445ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.445NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.124ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.124ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.124ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.124NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.384ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.384ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.384ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.384NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAQORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAQENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XAQNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
BA.2.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.2.3.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.569ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.569ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.569ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.569NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.524ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.524ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.524ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.524NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.596.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.596.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.596.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.596.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.473ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.473ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.473ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.473NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used